[This corrects the article DOI: 10.1016/j.apsb.2022.05.019.].

Although symptomatic treatment is widely applied in clinical practice， it is often regarded as a relatively low-level therapeutic method. Based on Traditional Chinese Medicine （TCM） state theory， the macroscopic， mesoscopic， and microscopic characterization parameters of TCM symptomatology are horizontally integrated， the full life cycle of states （pre-disease， incipient disease， manifest disease， post-disease） is vertically covered， and the cognitive system of "symptoms" is reconstructed from multiple dimensions. Accordingly， the application approach of symptomatic treatment at different state stages is proposed： implementing preventive intervention in the pre-disease state， strengthening the interception of disease progression in the incipient disease state， regulating dynamic development and treatment in the manifest disease state， and formulating a staged diagnosis and treatment strategy which focuses on functional rehabilitation in the post-disease state.

Imaging examination is a crucial part in diagnosis and treatment of central nervous system infection(CNSI),involving complex imaging sequences and parameters.This consensus was jointly written by multiple CNSI imaging experts in China,aimed to standardize imaging examination of CNSI.

Objective:To observe any effect of supplementing treatment according to the Early Start Denver model (ESDM) with repeated transcranial magnetic stimulation (rTMS) in the treatment of children with autism spectrum disorder (ASD).Methods:Sixty-seven children on the autism spectrum aged 2 or 3 years were randomly divided into a control group of 33 and an observation group of 34. Both groups were treated as specified by the ESDM for 24 weeks, but the observation group additionally received rTMS. At 12 and 24 weeks, both groups were evaluated using the Autism Behavior Checklist, the Childhood Autism Rating Scale (CARS), the revised version of the Repetitive Behavior Scale (RBS-R), Gesell Development Schedules, and the Autism Treatment Evaluation Checklist (ATEC).Results:The CARS, Gesell, RBS-R and ATEC results of both groups had improved significantly after 12 weeks, with further improvements observed another 12 weeks later, when the average Autism Behavior Checklist scores had also improved significantly. At that point the results of the observation group were significantly better than those of the control group, on average.Conclusions:Combining ESDM and rTMS can significantly relieve the main symptoms of autism and improve the comprehensive development of children on the autism spectrum 2 or 3 years old. Therefore, such combination is worthy of application in clinical practice.

Objective To analyze the clinical characteristics of patients with Streptococcus anginosus group(SAG)infected brain abscess and provide a reference basis for the clinical diagnosis and treatment of this disease.Methods The clinical information of 59 patients with brain abscess with SAG in Guangdong Sanjiu Brain Hospital from January 2016 to October 2023 was collected for retrospective statistical analysis.Results Among the 59 patients with brain abscess,there were 52(88.14%)male and 7(11.86%)female.Among 59 cases of SAG,there were 32(54.24%)in the Str.intermedius group,21(35.59%)in the Str.constellatus group and 6(10.17%)in the Str.anginosus group.The age of Str.intermedius group was less than that of Streptococcus constellatus group(36.75±20.06 years vs 50.43±16.17 years),and the difference was statistically significant(t=2.614,P<0.05).The common clinical symptom was headache,while the probability of fever was greater in the Str.intermedius group compared to the Str.constellatus group(t=4.174,P<0.05).Abscesses were commonly solitary and were located in the parietal and frontal lobes of the brain.Patients with Str.constellatus had a greater probability of developing mixed infections compared to patiens with Str.intermedius(57.14%vs 9.38%)with significant differences(t=14.257,P<0.05).Glycopeptide(vancomycin)plus carbapenem(meropenem)combination regimen was the most commonly used in both empiric and targeted dosing were 64.41%and 52.54%,respectively.No strains resistant to common antibiotics were identified.Conclusion The SAG causing brain abscesses are mainly Str.intermedius and Str.constellatus,and the age,symptoms and infection patterns of patients with brain abscesses caused by the two bacteria were different.SAG did not appear to be drug-resistant in the clinic,and the clinic could reasonably evaluate and adjust the anti-infection regimen based on the drug sensitivity results.

Objective To analyze the clinical characteristics of patients with Streptococcus anginosus group(SAG)infected brain abscess and provide a reference basis for the clinical diagnosis and treatment of this disease.Methods The clinical information of 59 patients with brain abscess with SAG in Guangdong Sanjiu Brain Hospital from January 2016 to October 2023 was collected for retrospective statistical analysis.Results Among the 59 patients with brain abscess,there were 52(88.14%)male and 7(11.86%)female.Among 59 cases of SAG,there were 32(54.24%)in the Str.intermedius group,21(35.59%)in the Str.constellatus group and 6(10.17%)in the Str.anginosus group.The age of Str.intermedius group was less than that of Streptococcus constellatus group(36.75±20.06 years vs 50.43±16.17 years),and the difference was statistically significant(t=2.614,P<0.05).The common clinical symptom was headache,while the probability of fever was greater in the Str.intermedius group compared to the Str.constellatus group(t=4.174,P<0.05).Abscesses were commonly solitary and were located in the parietal and frontal lobes of the brain.Patients with Str.constellatus had a greater probability of developing mixed infections compared to patiens with Str.intermedius(57.14%vs 9.38%)with significant differences(t=14.257,P<0.05).Glycopeptide(vancomycin)plus carbapenem(meropenem)combination regimen was the most commonly used in both empiric and targeted dosing were 64.41%and 52.54%,respectively.No strains resistant to common antibiotics were identified.Conclusion The SAG causing brain abscesses are mainly Str.intermedius and Str.constellatus,and the age,symptoms and infection patterns of patients with brain abscesses caused by the two bacteria were different.SAG did not appear to be drug-resistant in the clinic,and the clinic could reasonably evaluate and adjust the anti-infection regimen based on the drug sensitivity results.

Imaging examination is a crucial part in diagnosis and treatment of central nervous system infection(CNSI),involving complex imaging sequences and parameters.This consensus was jointly written by multiple CNSI imaging experts in China,aimed to standardize imaging examination of CNSI.

Objective:To observe any effect of supplementing treatment according to the Early Start Denver model (ESDM) with repeated transcranial magnetic stimulation (rTMS) in the treatment of children with autism spectrum disorder (ASD).Methods:Sixty-seven children on the autism spectrum aged 2 or 3 years were randomly divided into a control group of 33 and an observation group of 34. Both groups were treated as specified by the ESDM for 24 weeks, but the observation group additionally received rTMS. At 12 and 24 weeks, both groups were evaluated using the Autism Behavior Checklist, the Childhood Autism Rating Scale (CARS), the revised version of the Repetitive Behavior Scale (RBS-R), Gesell Development Schedules, and the Autism Treatment Evaluation Checklist (ATEC).Results:The CARS, Gesell, RBS-R and ATEC results of both groups had improved significantly after 12 weeks, with further improvements observed another 12 weeks later, when the average Autism Behavior Checklist scores had also improved significantly. At that point the results of the observation group were significantly better than those of the control group, on average.Conclusions:Combining ESDM and rTMS can significantly relieve the main symptoms of autism and improve the comprehensive development of children on the autism spectrum 2 or 3 years old. Therefore, such combination is worthy of application in clinical practice.

Objective:To investigate a new method for the reconstruction of hemifacial microsomia by sagittal osteotomy of the affected mandibular outer cortex combined with bone graft of mandibular outer cortex from healthy side.Methods:From March 2006 to March 2023, the clinical data of patients with hemifacial microsomia admitted to the Department of Craniomaxillofacial Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences were analyzed retrospectively. Preoperative diagnosis and surgical design were performed based on clinical manifestations and imaging findings. All cases were operated under general anesthesia. The affected mandibular outer cortex was previously split by an intraoral approach, and then the mandibular outer cortex of appropriate shape and size on the healthy side was harvested and grafted into the split bone space according to the preoperative design, following by internal rigid fixation. Complications, facial appearance improvement, and patient satisfaction were followed up. Photographs were taken preoperative, immediately postoperative and at the long-term(last) postoperative follow-up, and the severity of the deformity was analyzed. CT data from preoperative, immediate postoperative, and long-term follow-up visits were imported into Surgicase Proplan medical three-dimensional image workstation in Dicom format. The mandible was reconstructed using Segmentation, and the thickness of the mandible was measured during pre-operative, immediate post-operative and long-term follow-up visits. Anova with repeated measurement design was used to compare measurements and LSD test was used for multiple comparisons. The Kruskal-Wallis rank sum test were used to statistically analyze malformation severity. P< 0.05 is considered statistically significant. Results:A total of 39 patients were included in this study, including 13 females and 26 males, with an average age of (22.21±4.57) years (15-27 years). All patients were followed up for an average of (45.56±39.41) months (6-153 months) after surgery. The grafted mandibular outer cortex grows well with the adjacent bone tissue, and the mandibular angle and mandibular body are significantly wider. Of the 39 cases, 1 developed an infection 1 year after surgery, the titanium plate was exposed, and the patient healed after debridement and removal of the immobilizing splint. The facial appearance of the other patients improved significantly. Preoperative, immediate postoperative and long term follow up of mandibular thickness measurements were compared in pairs, and the differences were statistically significant (all P<0.05). The patient’s appearance satisfaction score: the preoperative score was [2.0(1.5, 2.0)] points, the immediate postoperative score was [4.0(4.0, 4.0)] points, the score of the last postoperative follow up was [4.0(4.0, 4.0)] points. There was statistical difference in satisfaction among the three groups ( P<0.01). The preoperative scores were compared with the scores of the immediate postoperative and the last postoperative follow-up respectively, and the differences were statistically significant( P<0.01). There was no statistical significance in satisfaction between the immediate postoperative score and the score of the last postoperative follow up ( P>0.05). Conclusion:The sagittal splitting osteotomy of the mandibular outer cortex is consistent with the features of mandibular anatomy, and provides a good condition for the grafting and healing of autogenous bone. Removing the outer cortex of the mandible on the healthy side not only increases the thickness of the affected side, but also decreases the width of the angle of the mandible on the healthy side, so as to effectively correct the asymmetric deformity of the mandible. The method is simple, with few complications and good results, and is one of the ideal treatments to correct hemofacial microsomia.

Currently,human health due to corona virus disease 2019(COVID-19)pandemic has been seriously threatened.The coronavirus severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)spike(S)protein plays a crucial role in virus transmission and several S-based therapeutic approaches have been approved for the treatment of COVID-19.However,the efficacy is compromised by the SARS-CoV-2 evolvement and mutation.Here we report the SARS-CoV-2 S protein receptor-binding domain(RBD)inhibitor licorice-saponin A3(A3)could widely inhibit RBD of SARS-CoV-2 variants,including Beta,Delta,and Omicron BA.1,XBB and BQ1.1.Furthermore,A3 could potently inhibit SARS-CoV-2 Omicron virus in Vero E6 cells,with EC50 of 1.016 pM.The mechanism was related to binding with Y453 of RBD deter-mined by hydrogen-deuterium exchange mass spectrometry(HDX-MS)analysis combined with quan-tum mechanics/molecular mechanics(QM/MM)simulations.Interestingly,phosphoproteomics analysis and multi fluorescent immunohistochemistry(mIHC)respectively indicated that A3 also inhibits host inflammation by directly modulating the JNK and p38 mitogen-activated protein kinase(MAPK)path-ways and rebalancing the corresponding immune dysregulation.This work supports A3 as a promising broad-spectrum small molecule drug candidate for COVID-19.